Tamarly Intelligence

Who Holds Actuate Therapeutics, Inc. (ACTU)? 64 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 64 holders, $21 million in total.

Largest holders

The 64 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
BIOS Capital Management, LP10,049,996$15 million+0%13F
Voss Capital, LP1,725,000$3 million+0%13F
VANGUARD CAPITAL MANAGEMENT LLC393,433$601,952-2%13F
AQR CAPITAL MANAGEMENT LLC127,493$195,064+370%13F
GEODE CAPITAL MANAGEMENT, LLC112,554$172,207-51%13F
Texas Capital Bank Wealth Management Services Inc102,612$156,997+8%13F
Palogic Value Management, L.P.100,000$153,000+0%13F
MILLENNIUM MANAGEMENT LLC96,684$147,927New13F
BlackRock, Inc.90,035$137,754-79%13F
ABS Direct Equity Fund LLC73,186$111,975+46%13F
ABS Investment Management LLC73,186$111,975New13F
VANGUARD FIDUCIARY TRUST CO54,497$83,380-13%13F
Rock Creek Group LLC39,263$60,072+0%13F
JANE STREET GROUP, LLC39,132$59,872New13F
HighTower Advisors, LLC36,461$55,785New13F
GOLDMAN SACHS GROUP INC35,498$54,312+186%13F
SFMG, LLC33,000$50,490+0%13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP28,182$43,118New13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC23,482$35,927-24%13F
STATE STREET CORP21,850$33,431-67%13F
NORTHERN TRUST CORP21,220$32,467-78%13F
Mariner, LLC21,082$32,257New13F
Gleason Group, Inc.19,028$29,113+0%13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO18,518$28,333-41%13F
Qube Research & Technologies Ltd15,256$23,342New13F
Apollon Wealth Management, LLC14,013$21,440New13F
IEQ CAPITAL, LLC13,890$21,252New13F
ACT Advisors, LLC.12,877$19,702New13F
DEUTSCHE BANK AG\12,235$18,720-66%13F
LPL Financial LLC11,965$18,306-8%13F
Sowell Financial Services LLC10,973$16,788New13F
Green Ridge Wealth Planning LLC10,000$15,300New13F
JPMORGAN CHASE & CO7,626$12,049+97%13F
Global Retirement Partners, LLC6,250$9,563New13F
Vanguard Global Advisers, LLC5,102$7,806+0%13F
Tower Research Capital LLC (TRC)3,634$5,560-37%13F
RHUMBLINE ADVISERS3,620$5,538-61%13F
UBS Group AG3,534$5,407+81%13F
MORGAN STANLEY3,490$5,340-49%13F
FMR LLC3,287$5,029-63%13F
PNC Financial Services Group, Inc.2,513$3,845+14682%13F
WELLS FARGO & COMPANY/MN2,446$3,742-58%13F
Arax Advisory Partners1,310$2,004+14456%13F
OSAIC HOLDINGS, INC.1,000$1,530+0%13F
BNP PARIBAS FINANCIAL MARKETS990$1,515-60%13F
Russell Investments Group, Ltd.673$1,030+15%13F
ROYAL BANK OF CANADA483$1,000-98%13F
BARCLAYS PLC421$645-81%13F
CITIGROUP INC395$604-21%13F
NISA INVESTMENT ADVISORS, LLC334$511+284%13F
Allworth Financial LP286$438+615%13F
EverSource Wealth Advisors, LLC265$406+657%13F
Integrated Wealth Concepts LLC181$278New13F
Essential Partners LLC167$256+248%13F
ROTHSCHILD INVESTMENT LLC124$190+854%13F
IFP Advisors, Inc73$112+7200%13F
GAMMA Investing LLC65$99-77%13F
Farther Finance Advisors, LLC46$70+557%13F
Fortitude Family Office, LLC30$46New13F
True Wealth Design, LLC29$45+107%13F
Virtu Financial LLC14,611$22New13F
HRT FINANCIAL LP14,034$21New13F
SJS Investment Consulting Inc.10$16+900%13F
JPL Wealth Management, LLC1$2New13F

Questions and answers

How many institutions hold Actuate Therapeutics, Inc.?
64 managers reported Actuate Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 61 the quarter before.
Who is the largest institutional holder of Actuate Therapeutics, Inc.?
BIOS Capital Management, LP, with 10,049,996 shares worth $15 million on its 13F for Q2 2026.
How many institutions bought or sold out of Actuate Therapeutics, Inc. in Q2 2026?
18 managers reported a new position and 15 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Actuate Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/actuate-therapeutics, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Who Holds Actuate Therapeutics, Inc. (ACTU)? 64 Institutional Holders, Q2 2026 | Tamarly